Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,424 public trials 2,855 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

NCT03537482

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations: Mayo Clinic Jacksonville, Florida, United States

Duke Unviersity Durham, North Carolina, United States

MDACC Houston, Texas, United States

St. Vincent Hospital Fitzroy, Victoria, Australia

View Trial Details

Recruiting

FeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethasone (HOVON174MM)

NCT06187441

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: NL-Den Bosch-JBZ 's-Hertogenbosch, Netherlands

NL-Almere-FLEVOZIEKENHUIS Almere Stad, Netherlands

NL-Amersfoort-MEANDERMC Amersfoort, Netherlands

NL-Amsterdam- UMC Amsterdam, Netherlands

View all 38 locations

View Trial Details

Recruiting

Observatory of Immunological Thrombopenic Purpura in the Brest Region

NCT06556888

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Hematology Department - Institute of Oncology and Hematology, University Hospital of Brest Brest, Brittany Region, France

View Trial Details

Recruiting

Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)

NCT06555315

Conditions: Anemia, Anemia of Prematurity, Extremely Low Birth Weight, +15 more
Locations: CHRISTUS Children's San Antonio, Texas, United States

View Trial Details

Recruiting

Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL

NCT06554626

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Drug Response Profiling (DRP) Registry Zurich for Hematological Malignancies

NCT06550102

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +11 more
Locations: University Children's Hospital Zurich Zurich, Canton of Zurich, Switzerland

View Trial Details

Recruiting

Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adolescents With ALL and Lymphoma

NCT05873322

Conditions: Drug-Induced Diabetes Mellitus, Glucose Intolerance, Glucose Metabolism Disorders, +16 more
Locations: Aarhus University Hospital Aarhus N, Denmark

View Trial Details

Recruiting

CML Pediatric ITK Response According to Molecular Identification at Diagnosis

NCT05605379

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: CHU de Bordeaux, Service Hématologie Biologique Bordeaux, France

View Trial Details

Recruiting

A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies

NCT06550713

Conditions: Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

Peking University international Hospital Beijing, Beijing Municipality, China

The Second Hospital of Hebei Medical University Shijiazhuang, Hebei, China

Harbin The First Hospital Harbin, Heilongjiang, China

View Trial Details

Recruiting

Myeloproliferative Neoplastic Diseases Observatory From Brest

NCT02897297

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations: CHRU de Brest Brest, France

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions